These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31521045)

  • 1. Metabolic profiling identifies TC and LDL as potential serum biomarkers for depressive symptoms in schizophrenia.
    Fang X; Chen L; Wang D; Yu L; Wang Y; Chen Y; Ren J; Tang W; Zhang C
    Psychiatry Res; 2019 Nov; 281():112522. PubMed ID: 31521045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid profile in schizophrenia: case control study.
    Mhalla A; Bel Hadj Salah W; Mensi R; Amamou B; Messaoud A; Gassab L; Douki W; Najjar MF; Gaha L
    Tunis Med; 2018 Jan; 96(1):22-29. PubMed ID: 30324988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum lipid profiles and schizophrenia: effects of conventional or atypical antipsychotic drugs in Taiwan.
    Huang TL; Chen JF
    Schizophr Res; 2005 Dec; 80(1):55-9. PubMed ID: 15964176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of metabolic parameters, neurotrophin-3, and neurotrophin-4 serum levels in women with schizophrenia and first-onset depression.
    Skibinska M; Kapelski P; Rajewska-Rager A; Szczepankiewicz A; Narozna B; Duda J; Dmitrzak-Weglarz M; Twarowska-Hauser J; Pawlak J
    Nord J Psychiatry; 2019 Feb; 73(2):96-103. PubMed ID: 30654674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.
    Lepira FB; M'Buyamba-Kabangu JR; Kayembe KP; Nseka MN
    Cardiovasc J S Afr; 2005; 16(5):249-55. PubMed ID: 16307156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, demographic and clinical features of comorbid depressive symptoms in drug naïve patients with schizophrenia presenting with first episode psychosis.
    Dai J; Du X; Yin G; Zhang Y; Xia H; Li X; Cassidy R; Tong Q; Chen D; Teixeira AL; Zheng Y; Ning Y; Soares JC; He MX; Zhang XY
    Schizophr Res; 2018 Mar; 193():182-187. PubMed ID: 28651908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latent Toxoplasma gondii infection is associated with decreased serum triglyceride to high-density lipoprotein cholesterol ratio in male patients with schizophrenia.
    Sagud M; Vlatkovic S; Svob Strac D; Sviben M; Zivkovic M; Vilibic M; Vuksan-Cusa B; Mihaljevic-Peles A; Pivac N
    Compr Psychiatry; 2018 Apr; 82():115-120. PubMed ID: 29477703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between serum adiponectin levels, cardiometabolic indices and metabolic syndrome in schizophrenia.
    Tay YH; Lee J
    Asian J Psychiatr; 2019 Jun; 43():1-6. PubMed ID: 31059867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LDL cholesterol relates to depression, its severity, and the prospective course.
    Wagner CJ; Musenbichler C; Böhm L; Färber K; Fischer AI; von Nippold F; Winkelmann M; Richter-Schmidinger T; Mühle C; Kornhuber J; Lenz B
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():405-411. PubMed ID: 30779936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective plasma lipid profiling in individuals with and without depression.
    Enko D; Brandmayr W; Halwachs-Baumann G; Schnedl WJ; Meinitzer A; Kriegshäuser G
    Lipids Health Dis; 2018 Jun; 17(1):149. PubMed ID: 29945617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between long-term use of a typical antipsychotic medication by Chinese schizophrenia patients and the bone turnover markers serum osteocalcin and β-CrossLaps.
    Zhang B; Deng L; Wu H; Lu X; Peng L; Wu R; Guo W; Chen J; Li L; Zhao J
    Schizophr Res; 2016 Oct; 176(2-3):259-263. PubMed ID: 27377977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of triglycerides, cholesterol, LDL, HDL and glucose in patients with schizophrenia, unipolar depression and bipolar disorder.
    Wysokiński A; Strzelecki D; Kłoszewska I
    Diabetes Metab Syndr; 2015; 9(3):168-76. PubMed ID: 25943411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between vaspin and PANSS scores in schizophrenia patients with obesity.
    Ertekin H; Uysal S; Aydın M; İlhan B; Ertekin YH
    Int J Psychiatry Med; 2020 Jul; 55(4):264-280. PubMed ID: 32050814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trajectory classes of violent behavior and their relationship to lipid levels in schizophrenia inpatients.
    Chen SC; Chu NH; Hwu HG; Chen WJ
    J Psychiatr Res; 2015; 66-67():105-11. PubMed ID: 26004299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated depressive symptoms and compositional changes in LDL particles in middle-aged men.
    Lehto SM; Ruusunen A; Niskanen L; Tolmunen T; Voutilainen S; Viinamäki H; Kaplan GA; Kauhanen J
    Eur J Epidemiol; 2010 Jun; 25(6):403-9. PubMed ID: 20414796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum IL-1ra, a novel biomarker predicting olanzapine-induced hypercholesterolemia and hyperleptinemia in schizophrenia.
    Lin Y; Peng Y; He S; Xu J; Shi Y; Su Y; Zhu C; Zhang X; Zhou R; Cui D
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):71-78. PubMed ID: 29410009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A twenty-four-week, open-label study on ziprasidone's efficacy and influence on glucolipid metabolism in patients with schizophrenia and metabolic disorder.
    Li CH; Shi L; Zhan GL; Rao SZ; Zhang H
    Eur Rev Med Pharmacol Sci; 2013 Aug; 17(16):2136-40. PubMed ID: 23893178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in serum HDL level is associated with less negative symptoms after one year of antipsychotic treatment in first-episode psychosis.
    Gjerde PB; Dieset I; Simonsen C; Hoseth EZ; Iversen T; Lagerberg TV; Lyngstad SH; Mørch RH; Skrede S; Andreassen OA; Melle I; Steen VM
    Schizophr Res; 2018 Jul; 197():253-260. PubMed ID: 29129510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cholesterol and treatment-resistance in schizophrenia.
    Boston PF; Dursun SM; Zafar R; Reveley MA
    Biol Psychiatry; 1996 Sep; 40(6):542-3. PubMed ID: 8879475
    [No Abstract]   [Full Text] [Related]  

  • 20. Psychopharmacological Treatment in the RAISE-ETP Study: Outcomes of a Manual and Computer Decision Support System Based Intervention.
    Robinson DG; Schooler NR; Correll CU; John M; Kurian BT; Marcy P; Miller AL; Pipes R; Trivedi MH; Kane JM
    Am J Psychiatry; 2018 Feb; 175(2):169-179. PubMed ID: 28945118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.